The proposed project, Neuropathology of CTE and Late Effects of TBI: Toward In-Vivo Diagnostics is a multi- center and multi-disciplinary study designed to dramatically increase our understanding of chronic traumatic encephalopathy (CTE) and other late effects of traumatic brain injury (TBI). TBI is a major public health concern in the US, as the current prevalence of TBI in the US is unprecedented. Some TBI survivors experience particularly poor outcomes as they age; these include accelerated cognitive and health decline, dementia, and in some cases, CTE. CTE is thought to be a tauopathy but has been described only in convenience samples of people with repetitive head trauma. CTE is incompletely described in individuals with mild, moderate and severe TBI. The population incidence and prevalence, risk factors, and causal role of multifocal tauopathy on associated symptoms are unknown. Overlapping clinical features, postmortem pathologies and patterns of involvement exist in TBI, CTE, and Alzheimer's disease pose challenges to accurate diagnosis. Premortem diagnosis of CTE is currently impossible. The neuropathological consequences of single mild or moderate-severe TBI and its relationship with CTE and known dementias are unclear. The proposed project will leverage extensive resources from an ongoing population-based prospective cohort study of brain aging (Adult Changes in Thought; ACT, n=2,305) which includes excellent medical, behavioral, and genetic characterization of a cohort (20% of whom have a history of mild-moderate TBI) in addition to state-of-the-art neuropathology workup upon death. Neuropathological study of TBI effects can begin immediately in the existing ACT autopsy sample (n=489, 20% with TBI exposure). Additional cohorts of TBI- exposed individuals will come from the Brain Injury Research Center at Mount Sinai (n=150 individuals with moderate-severe TBI), the University of Texas Southwestern (n=50 retired boxers with repetitive TBI exposure), and the National Football League (n=76 retired players with repetitive TBI exposure). All participants in the proposed study (ACT and other sites) will undergo uniform harmonized neurobehavioral assessment (chosen to maximize correspondence with existing large-scale TBI and dementia studies), MRI scan, and genomic analysis. Those individuals who expire during the course of the study will undergo ex-vivo neuroimaging and extensive neuropathological exam using state-of-the-art techniques (such as Histelide) designed to quantify tau and A in whole brain specimens. Only by examining postmortem pathology in a sample of individuals with varying levels of TBI exposure who are well characterized during life (as proposed herein) can postmortem pathology facilitate identification of in-vivo biomarkers that can act as diagnostic tools. This project represents the most systematic and scientifically rigorous effort to date to develop a more complete understanding of the long-term clinical and neuropathological sequelae of single and multiple TBI.

Public Health Relevance

Traumatic brain injury (TBI) is a major public health problem in the United States. Long-term effects of single or multiple TBI are largely unknown, and it is unclear how they relate to the development of neurodegenerative processes such as dementia or chronic traumatic encephalopathy (CTE). The proposed project will leverage existing research infrastructure and apply state-of-the-art epidemiological, neuroimaging, genetic, and neuropathological methods, combined with statistical methods that account for any selection bias, to improve our knowledge about late effects of TBI and CTE in the population.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01NS086625-03
Application #
8990063
Study Section
Special Emphasis Panel (ZNS1)
Program Officer
Bellgowan, Patrick S F
Project Start
2014-01-01
Project End
2017-12-31
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
3
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Physical Medicine & Rehab
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Iverson, Grant L; Keene, C Dirk; Perry, George et al. (2018) The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features. J Alzheimers Dis 61:17-28
Bianciardi, Marta; Strong, Christian; Toschi, Nicola et al. (2018) A probabilistic template of human mesopontine tegmental nuclei from in vivo 7T MRI. Neuroimage 170:222-230
Aganj, Iman; Harisinghani, Mukesh G; Weissleder, Ralph et al. (2018) Unsupervised Medical Image Segmentation Based on the Local Center of Mass. Sci Rep 8:13012
Wu, Jianxiao; Ngo, Gia H; Greve, Douglas et al. (2018) Accurate nonlinear mapping between MNI volumetric and FreeSurfer surface coordinate systems. Hum Brain Mapp :
Magnain, Caroline; Augustinack, Jean C; Tirrell, Lee et al. (2018) Colocalization of neurons in optical coherence microscopy and Nissl-stained histology in Brodmann's area 32 and area 21. Brain Struct Funct :
Li, Yi; Barkovich, Matthew J; Karch, Celeste M et al. (2018) Regionally specific TSC1 and TSC2 gene expression in tuberous sclerosis complex. Sci Rep 8:13373
Siless, Viviana; Chang, Ken; Fischl, Bruce et al. (2018) AnatomiCuts: Hierarchical clustering of tractography streamlines based on anatomical similarity. Neuroimage 166:32-45
Polimeni, Jonathan R; Renvall, Ville; Zaretskaya, Natalia et al. (2018) Analysis strategies for high-resolution UHF-fMRI data. Neuroimage 168:296-320
Zaretskaya, Natalia; Fischl, Bruce; Reuter, Martin et al. (2018) Advantages of cortical surface reconstruction using submillimeter 7 T MEMPRAGE. Neuroimage 165:11-26
Wang, Hui; Magnain, Caroline; Wang, Ruopeng et al. (2018) as-PSOCT: Volumetric microscopic imaging of human brain architecture and connectivity. Neuroimage 165:56-68

Showing the most recent 10 out of 27 publications